Clinical trial
Gemcitabine With or Without Radiation Therapy in Treating Patients With…
NCT00057876 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00057876 |
|---|---|
| Title | Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer |
| Official title | A Randomized Phase III Study Of Gemcitabine In Combination With Radiation Therapy Versus Gemcitabine Alone In Patients With Localized, Unresectable Pancreatic Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Radiation Therapy Oncology Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Gemcitabine, radiation therapy |
| Enrollment | 74 |
| Start date | Aug 29, 2003 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Apr 9, 2003 |
| Last update posted | Jul 5, 2023 |
| Countries | South Africa, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: